Vemurafenib plus Rituximab as a chemotherapy-free alternative to Cladribine followed by MRD-guided Rituximab in front-line hairy Cell leukemia (HCL): a phase-2 randomized multicenter trial
An Observational Retrospective Cohort Study of Lenalidomide Monotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) to Generate a Historical Control for Clinical Trial MOR208C206.
Upadacitinib treatment patterns, achievement of treatment targets and maintenance of response in moderate to severe Rheumatoid Arthritis patients in real-world practice. (UPHOLD)
A Phase 3 randomized, placebo-controlled, double-blind, parallel-group program to evaluate efficacy and safety of filgotinib in adult subjects with active axial spondyloarthrits-
A multicenter, prospective, observational cohort study to evaluate the real-world safety and effectiveness of ErelziTM, an etanercept biosimilar (COMPACT). Studio di coorte osservazionale, multicentrico, prospettico volto a valutare la sicurezza e l'efficacia nel mondo reale di Erelzi, un biosimilare di Etanercept (COMPACT). (GP15-501)<
sperimentatore principale: Prof. Salvatore De Vita
Studio multicentrico, randomizzato, in doppio cieco, controllato verso placebo per valutare la sicurezza e l’efficacia di Upadacitinib in soggetti affetti da arterite a cellule giganti. A Multicenter randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Upadacitiniv in subjects with giant cell Arteritis. (M16-852)
sperimentatore principale: Prof. Salvatore De Vita
Remissione clinica e ultrasonografica in pazienti affetti da artrite reumatoide naïve o failure ai farmaci biologici, con attività di malattia moderata / severa, trattati con upadacitinib: studio di real-life.
Clinical and ultrasonography remission in bio-naïve and bio-failure RA patients with moderate to high disease activity, treated with Upadacitinib: a real-life study.